Stop Buying the AI Story. Start Investing in the Reality Being Built.

AI, biotech, and geopolitics are all converging on one theme: permission. Who gets access, who gets margin, and who becomes the toll collector. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  

You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here. Prefer to view this content on our website? Click here. AI Just Became a Controlled Export. That Changes Who Wins.  A quick note from Behind the Markets Wall Street is addicted to one thing: pretending the world is frictionless. Capital flows. Chips ship. Supply chains hum. Everybody wins. That fantasy is over. The next phase of this market isn't about "growth vs. value." It's about permission — who gets it, who doesn't, and which companies become the toll booths. 1) AI Is Getting Nationalized — Export Controls Are Becoming an Investment Model Reuters reported U.S. officials are debating a new framework for exporting AI chips that would explicitly tie exports to U.S. investment commitments and security assurances. Here's the detail that should make every self-directed investor sit up: Under 1,000 chips might require a license. Up to 100,000 chips: foreign buyers would need government-to-government assurances. Up to 200,000 chips could trigger U.S. official visits. And at 200,000 chips or more, exports could depend on foreign nations investing in U.S. AI data centers or providing security assurances. This is not "regulation." This is an industrial policy business model. The pattern has been escalating all year. In January, BIS shifted from blanket denial to case-by-case licensing for H200-class chips to China — but with conditions: third-party testing on U.S. soil before every shipment, volume caps limiting China-bound shipments to 50% of domestic sales, and a 25% tariff on each transaction. The House passed the Remote Access Security Act (369–22) to close the "cloud loophole" — where foreign companies were renting GPU time in third-country data centers to bypass physical chip controls. And the AI Overwatch Act would give Congress 30-day review power over every export license for advanced AI chips to adversaries. Chinese firms reportedly ordered more than 2 million H200 chips for 2026. Nvidia's CEO has estimated the China market at $50 billion annually. Those are the stakes being regulated. This creates a new class of winners: the companies that can navigate licensing, compliance, and monitoring. The firms that build and operate domestic data center capacity. And the infrastructure layer that gets pulled into the U.S. because that's the price of admission. One company that becomes more valuable every time export controls tighten: Company: Nvidia (SYM: NVDA) The dominant AI chip designer whose products are at the center of every export control framework — and whose domestic data center demand accelerates as foreign access gets restricted. Every time Washington tightens the rules on who can buy AI chips abroad, more demand gets redirected domestically. Nvidia doesn't just sell chips — it sells the compute architecture that data centers are being built around. The $1.4 trillion utility buildout, the hyperscaler capex surge (projected to exceed $470 billion in 2026 alone), and the export-driven requirement that foreign nations invest in U.S. AI infrastructure — all of it flows through Nvidia's product stack. The export controls don't hurt Nvidia the way the market feared in 2025. They restructure the market around Nvidia's installed base. Bottom line: AI is drifting from a global free-for-all into a permissioned market. The alpha won't just be in the hottest chips — it'll be in the bottlenecks created by rules. Med-X Inc The Real Opportunity to Become a Shareholder Is Now! Med-X is a botanical pesticide company replacing chemical toxins with proven, plant-based solutions. With $6.4M in sales, no long-term debt, and expanding into 41 markets, the company is positioned to capture the surge in global demand for safer pest control. As the world shifts to sustainable solutions, early investors could benefit from the same type of market recognition that transformed sectors led by innovators like Tesla and Zoom – only this time, in clean pest control. Simpler. Safer. More Effective Pesticides. Become a Med-X shareholder at $4 per share before the Nasdaq plans unfold... Disclosures This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com 2) The Underfollowed Trade: "Compliance Tech" and the Boring Enablers of AI Most retail investors think "AI winners" means one of two things: buy the mega-cap chip brand, or chase some app with a pitch deck. But when Washington starts counting chips like they're missiles, the market creates demand for something boring and lucrative: export compliance systems, usage monitoring, security tooling, audit trails, and policy-driven supply chain mapping. Reuters said one proposed exemption would require exporters to oversee the chips, and recipients to use software preventing the chips from being interconnected into a "cluster." That sentence is easy to skip. It's also a flashing neon sign. BIS now requires license applicants to certify that their customers demonstrate "sufficient" security procedures. Independent testing labs — U.S.-headquartered, with no ownership ties to China — must test and certify every export shipment before it leaves the country. The AI Overwatch Act would impose automatic denial on any chip first marketed after January 1, 2026, that approaches controlled performance thresholds — meaning the compliance infrastructure has to run in real time, not retrospectively. The AI boom is turning into a "trust-but-verify" economy. And verification always creates a vendor stack. One company positioned at the center of compliance-driven AI infrastructure: Company: Palantir Technologies (SYM: PLTR) The data analytics and AI platform deeply embedded in U.S. government operations, intelligence, and defense — with the security clearances and compliance architecture that the "permissioned AI" era requires. Palantir is currently trading around $147.31. The company's entire business model is built on operating in classified and highly regulated environments. When the government mandates real-time monitoring, audit trails, and security verification for AI chip deployments — domestically and abroad — Palantir's Gotham and Foundry platforms are the kind of infrastructure that gets pulled into the stack. The company recently signed multi-billion-dollar-ceiling contracts with the Pentagon, and its tools are already embedded in DOD operations. In a world where AI compute gets governed like defense procurement, Palantir becomes less of a "tech stock" and more of a "compliance infrastructure" play. Bottom line: When everything is regulated, the "boring" enablers outperform the sexy narrative stocks — because they get paid no matter who wins the arms race. 3) Biotech's Retail Trap Is Back: Binary FDA Calendars and the Liquidity Ambush The quiet part out loud: retail loves biotech because it feels like a cheat code. A drug gets approved, the stock doubles. Except most of the time the market front-runs the hope, then dumps the news. Here's the contrarian move: stop thinking like a gambler and start thinking like a capital allocator. Is the approval already priced? What happens if it's "approve with label limits"? Does the company need to raise cash either way? Who owns the float, and what happens when they hit the sell button? The biotech M&A cycle we covered earlier this month — Big Pharma sitting on $1 trillion in cash, more than 20 acquisitions over $1 billion expected in 2026 — creates a second lens for FDA events. An approved drug with clean data and manufacturing readiness doesn't just get a stock pop. It gets an acquirer's attention. The play isn't the binary bet on approval day. It's positioning before the approval in names that check the acquirer's boxes — and avoiding the names that will need to raise capital regardless of the FDA outcome. One ETF for broad biotech exposure without single-name binary risk: ETF: SPDR S&P Biotech ETF (SYM: XBI) Equal-weighted biotech exposure that spreads risk across dozens of small and mid-cap names — capturing the sector's M&A and approval upside without the liquidity ambush of a single FDA date. XBI's equal-weight structure is the key differentiator. Unlike cap-weighted biotech ETFs that concentrate in a few mega-caps, XBI gives proportional exposure to the small and mid-cap names that are actual acquisition targets and FDA catalyst plays. When the M&A cycle accelerates and approvals hit, the portfolio captures the premium spread across dozens of names. When a single approval disappoints, the equal weighting limits the damage. It's the instrument for investors who believe the biotech thesis — patent cliff, M&A acceleration, pipeline innovation — without wanting to bet their account on a single drug's review date. Bottom line: FDA dates don't hand you easy money. They hand you a volatility regime. If you don't plan for the financing and the positioning, you're the exit liquidity. Trade Algo A critical message for traders This is a critical message for traders —  Listen, OpenAI CEO Sam Altman recently spoke at the Axel Springer Global Reporters Network in Berlin, where he said about jobs: “I can easily imagine a world where 30-40% of the tasks that happen in the economy today get done by AI in the not very distant future,” said Altman. The trend is becoming clear. The future will belong to those people who understand how to work WITH AI to accomplish their goals. Those who don’t will likely fall behind. TradeAlgo offers AI tools for retail investors to stay ahead of the curve. How? TradeAlgo has developed a groundbreaking tech called Dark Flow AI.  The tech uses artificial intelligence to scan through highly secretive trades in dark pools and spot stocks with the biggest surge in irregular volume. This may boost traders’ odds of getting into trades just before major price movements.  As a Behind the Markets reader, TradeAlgo would like to offer you a SPECIAL gift where you can sign up for their SMS “dark pool alerts” for FREE.  4) Macro Reality Check: Geopolitics Isn't a One-Day Candle Even when stocks keep their composure, markets are being forced to trade the real world again. The ceasefire is now two weeks old and fraying. The Islamabad talks failed. The U.S. naval blockade of Iranian ports is fully operational. The Pentagon is deploying another 10,000 troops to the region. And Trump is simultaneously saying the war is "very close to over" while threatening to bomb every bridge and power plant in Iran. Energy shocks feed into inflation expectations. Inflation expectations change the Fed's flexibility. And the Fed's flexibility is the oxygen for risk assets. That chain hasn't broken — it's just been temporarily anesthetized by "deal hopes." Here's the math that hasn't changed: the EIA forecasts Brent peaking at $115 in Q2, gasoline at $4.30/gallon in April, and diesel above $5.80/gallon. The Fed is stuck at 3.50–3.75% with no cuts in sight. And tariffs have added 3.1% to core goods prices — the "entirety of excess inflation" in that category, per the Fed's own research. Not every stock deserves to trade like "rates are coming down." Not every balance sheet can handle another round of input-cost pressure. One ETF built for a world where geopolitics and inflation stay elevated: ETF: Invesco DB Commodity Index Tracking Fund (SYM: DBC) Broad commodity exposure across energy, agriculture, and industrial metals — the asset class that historically performs best when inflation is persistent and geopolitical risk stays elevated. DBC isn't a "bet on oil." It's a bet that the physical world — energy, food, metals — stays more expensive than the market is pricing. When Brent is forecast to average above $90 for the year, gasoline is above $4, and two simultaneous supply disruptions (Hormuz + Baltic) remain unresolved, the commodity complex has a floor under it that equity valuations don't. DBC gives you diversified exposure to that floor without picking a single commodity or a single conflict outcome. Bottom line: The market can ignore geopolitics for a while. Your portfolio can't. Price the second-order effects: margins, credit, and consumer behavior. Before You Go If AI is truly the next industrial revolution… why is it already being treated like a controlled export commodity? That's not a reason to get bearish. It's a reason to stop buying the story Wall Street sells, and start investing in the reality being built. Priority Gold Only One President in 50 Years Has Had the Guts to Take On the Fed. He's Back. And He's About to Act. Biden spent four years printing money and calling it prosperity. The result? The worst inflation in a generation. Your groceries. Your gas. Your savings. All torched. Quietly. Deliberately. On purpose. Trump has known this game for decades. He's the only president in modern history willing to say out loud what the establishment has hidden for 50 years. And now insiders are saying he's preparing to sign an executive order that could change everything. → Click here to learn what Trump's executive order could mean for your money. Are there any other market stories you're following this week? What other sectors of the market are you focusing on in 2026? Hit "reply" to this email and let us know your thoughts! Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. Behind the Markets Unsubscribe invisiblelink

NEW STRATEGY REPLAY: 0DTE Options Trader (Has Been Hitting Up to 500 Percent?)

Never Before Seen and the Performance is Insane!

Hey Trader, We just wrapped up back-to-back LIVE training sessions where, for the first time ever… We revealed our SAME-DAY strategy for QQQ Options. Tap here to watch your replay of today’s event. This is the official introduction of... 0DTE Options Trader It trades options on QQQ with Zero Days Until Expiration. This is not a swing strategy. Not an overnight system. And definitely not something where you sit around waiting days for a move. This is a same-day strategy. In… and out… in a matter of hours. No overnight risk. No drawn-out holding periods. No tying up capital for days at a time. Just fast, rules-based execution. Built from over 37 years of real-world trading experience. And today marked the first time we’ve ever made it available. So why 0DTE options? Because they represent one of the most explosive opportunities in the entire market right now. These are options that expire the SAME DAY. Which means… When you catch the move correctly… The leverage can be massive. But here’s the key… We’re not guessing. We’re not over-trading. And we’re not chasing random momentum. We’re using a structured system, built around the following... - Opening range breakouts - VWAP confirmation - Volume-based validation This proprietary combination has created one of the most high-performance systems I've ever seen. And it's all executed on a precise 5-minute chart. Let me show you what that looks like… (All examples come directly from today’s presentation) • The QQQ March 20 586 Puts Entered at $1.22 Closed 2/3 of the position at +50% And the remaining contracts surged to +500% Generating +$1,586. • The QQQ December 12 618 Puts Produced +$1,900 with a +50% first target and a +500% runner • The QQQ February 3 616 Puts Delivered another +50% and +500% move Generating +$1,870 Not all winning trades will hit +500%. • The QQQ April 13 612 Calls Closed with a +50% gain on most contracts And +224.56% on the remainder For +$854 in total profit Since January 1st of 2024, this strategy is up +$29,637, which is +$592.74% on a $5,000 model account. So it's easy to see why we're so excited to share it with you! (Past performance does not guarantee future results, examples allocating up to $1k per trade) And yes… We also show losses. Because this is real trading, not fairy dust. • The QQQ February 6 610 Calls Closed for -51.52% No excessive hype. Just disciplined execution. Now here’s where this gets interesting… This strategy is designed for SPEED. The average holding period? Less than ONE trading day. In fact… Trades are typically entered between 9:50 AM and 10:05 AM ET. Which means… You only need about 15 minutes per day to catch these setups. Here’s how the structure works: • +50% target on 2/3rds of the position. • -50% stop on the full position. • A +500% target on the remaining 1/3rd. So once that first target is hit… You get your capital back and there's virtually no risk in the trade. You simply let the remainder run! And here’s something most traders are shocked by... The average contract price has been under $0.85. Which means you’re not risking massive capital per trade. But you’re still positioned for explosive moves. Even better… This strategy trades BOTH directions. Calls when the market breaks higher. Puts when the market breaks lower. So no matter what QQQ does… You’re positioned for opportunity. QQQ is the Nasdaq ETF and it's EXTREMELY liquid. Which means trading it is super easy.  It's easy to get in. Easy to get out. And the "slippage" is minimal. And with the Pattern Day Trader rule going away… There’s never been a better time to take advantage of same-day trading opportunities like this. At the core of the 0DTE Options Trader is a very specific opening range breakout setup. We start by defining the high and low from the first 15 minutes of each trading day. We do that on the 5-minute chart. That opening range becomes our line in the sand. From there, we’re not guessing direction, we’re waiting for confirmation. If a 5-minute candle closes above that range, it signals potential upside momentum. If it breaks below, it signals downside pressure. But we don’t stop there. We layer in VWAP (Volume-Weighted Average Price) and our unique BigTrends Volume Confirmation indicator to validate that institutional traders are participating, not just retail noise. And if the move doesn’t happen quickly, then we simply don’t trade. This keeps the system clean, disciplined, and focused on high-probability setups within a tight window between 9:50 AM and 10:05 AM ET. Let's use an analogy from the thoroughbred horse world... Instead of guessing which horse might win before the gates open, you wait to see which horse breaks out ahead early and shows real strength. Then, you align yourself with that momentum. That’s exactly what this system is doing. It’s not predicting, it’s reacting to real-time price action and confirmed strength. And once you’re in, the structure takes over, scaling out at +50% to reduce risk and letting a smaller portion ride for the potential of much larger gains. It’s a rules-based, momentum-driven approach that removes emotion and replaces it with a repeatable process built for speed and precision. Now… For the first time ever… We’re opening the doors to 0DTE Options Trader. But only to a very small group. Here’s how it works... You will get: 24 Months of 0DTE Options Trader Alerts Real-time trade notifications Sent directly to your email and mobile device So you can act the moment a setup triggers. Plus, you’ll also receive: • The 0DTE Options Trader Settings and Rules Sheet (So you can mirror the exact framework) • Weekly Video Updates (Ongoing training and market context) • Direct Access to the Analyst Team (Get answers fast, without guesswork) The total value of this package is $7,128. But for this initial release… We’re doing something outlandish. You can lock in the full 2-year package for just $1,997. And it gets even better... Use promo code DAY1000 and you'll save an extra $1,000 instantly. That brings your total investment down to just $997. Now here’s the part that makes this truly unprecedented… When you claim this package today… You’ll be upgraded to LIFETIME ACCESS for FREE. No renewals. No expiration date. No paying again down the road. Just ongoing access to every trade this strategy generates! Go here to grab your trades... (This refers to the lifetime of the subscriber. If the product is discontinued, access may transfer to a comparable offering.) But there’s a catch. This is limited to the first 25 traders. Because this is the first time we’ve ever released 0DTE Options Trader… We’re controlling the rollout. Tap here to claim your spot and get upgraded to LIFETIME ACCESS for FREE. You’ll also be invited to a LIVE Strategy Session on Tuesday, April 28th at 4:00 PM ET Where we break down every detail… And give you the full system, step-by-step. But you’ll want to act quickly. Because this is... - A brand-new strategy - First-time access - And it has some of the best performance we've ever seen! Tap here to claim your real-time trade alerts (and all the free bonuses)... Trade Well, Price Headley Founder and CEO of BigTrends P.S. This is the first time 0DTE Options Trader has ever been available. The first 25 traders get access… and the LIFETIME upgrade. After that, the door closes. Be sure to use your DAY1000 promo code, it will save you $1,000! Yes, Give Me Access to "0DTE Options Trader" Alerts, Plus a $1,000 Instant Gift Card, and the LIFETIME Upgrade for FREE! The information above reflects the track record of each of BigTrends.com’s trade alerts for this product during the period of time identified. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don’t trade with money you can’t afford to lose. BigTrends.com does not represent that any account will or is likely to achieve profits or losses similar to those discussed. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed are for illustrative purposes only and not to be construed as specific advisory recommendations. Information shown is intended for informational purposes only. BigTrends.com is a publisher and the information provided through its products and services are for informational purposes only. To the extent any such information is deemed to be advice, such information is impersonal and not tailored to the investment needs of any specific person. BigTrends.com is not restricted from owning individual securities or options. In addition, certain BigTrends.com affiliates and employees may, from time to time, have long and short positions in, or buy or sell the securities, or derivatives thereof, of companies mentioned in BigTrends.com’s products and may take positions inconsistent with the views expressed by BigTrends.com. Unsubscribe HIA Corp. 201 West Vine Street Lexington, Kentucky 40507 United States